BlackRock, Inc. 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-07 4:10 pm Purchase | 2024-07-31 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 5,459,941 10.000% | 2,827,262 (+107.39%) | Filing |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 2,632,679 6.000% | 1,690,013 (+179.28%) | Filing |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 942,666 2.500% | -1,587,065 (-62.74%) | Filing |
| 2021-02-01 08:30 am Purchase | 2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 2,529,731 6.800% | 412,537 (+19.49%) | Filing |
| 2020-02-06 09:10 am Purchase | 2019-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BlackRock Inc. BLK | 2,117,194 5.700% | 258,176 (+13.89%) | Filing |